Cargando…
Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids
Inhibition of RTK pathways in cancer triggers an adaptive response that promotes therapeutic resistance. Because the adaptive response is multifaceted, the optimal approach to blunting it remains undetermined. TNF upregulation is a biologically significant response to EGFR inhibition in NSCLC. Here,...
Autores principales: | Gong, Ke, Guo, Gao, Beckley, Nicole A., Yang, Xiaoyao, Zhang, Yue, Gerber, David E., Minna, John D., Burma, Sandeep, Zhao, Dawen, Akbay, Esra A., Habib, Amyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636603/ https://www.ncbi.nlm.nih.gov/pubmed/34853306 http://dx.doi.org/10.1038/s41467-021-27276-7 |
Ejemplares similares
-
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment()()
por: Gong, Ke, et al.
Publicado: (2020) -
Primary resistance to EGFR inhibition in glioblastoma is mediated by a TNF-JNK-Axl-ERK signaling axis
por: Guo, Gao, et al.
Publicado: (2017) -
Targeting RTK Signaling Pathways in Cancer
por: Regad, Tarik
Publicado: (2015) -
Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging
por: Zhang, Liang, et al.
Publicado: (2016) -
On the Problem of Double-Filtering in PPP-RTK
por: Khodabandeh, A., et al.
Publicado: (2022)